{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T23:44:28Z","timestamp":1793922268921,"version":"4.8.0"},"reference-count":45,"publisher":"Springer Science and Business Media LLC","issue":"1","content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Neuroinflammation"],"published-print":{"date-parts":[[2008,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Objective<\/jats:title>\n            <jats:p>A fatality in one multiple sclerosis (MS) patient due to acute idiopathic thrombocytopenic purpura (ITP) and a near fatality in another stimulated our interest in platelet function abnormalities in MS. Previously, we presented evidence of platelet activation in a small cohort of treatment-naive MS patients.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods<\/jats:title>\n            <jats:p>In this report, 92 normal controls and 33 stable, untreated MS patients were studied. Platelet counts, measures of platelet activation [plasma platelet microparticles (PMP), P-selectin expression (CD62p), circulating platelet microaggragtes (PAg)], as well as platelet-associated IgG\/IgM, were carried out. In addition, plasma protein S activity was measured.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results<\/jats:title>\n            <jats:p>Compared to controls, PMP were significantly elevated in MS (p &lt; 0.001) and CD62p expression was also markedly elevated (p &lt; 0.001). Both are markers of platelet activation. Platelet-associated IgM, but not IgG, was marginally elevated in MS (p = 0.01). Protein S in MS patients did not differ significantly from normal values.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusion<\/jats:title>\n            <jats:p>Platelets are significantly activated in MS patients. The mechanisms underlying this activation and its significance to MS are unknown. Additional study of platelet activation and function in MS patients is warranted.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1186\/1742-2094-5-27","type":"journal-article","created":{"date-parts":[[2008,6,27]],"date-time":"2008-06-27T18:12:33Z","timestamp":1214590353000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":164,"title":["Evidence of platelet activation in multiple sclerosis"],"prefix":"10.1186","volume":"5","author":[{"given":"William A","family":"Sheremata","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenche","family":"Jy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lawrence L","family":"Horstman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yeon S","family":"Ahn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J Steven","family":"Alexander","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alireza","family":"Minagar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2008,6,27]]},"reference":[{"key":"144_CR1","doi-asserted-by":"publisher","first-page":"929","DOI":"10.1001\/archneurpsyc.1935.02250170015002","volume":"33","author":"TJ Putnam","year":"1935","unstructured":"Putnam TJ: Studies in multiple sclerosis (iv) 'encephalitis' and sclerotic plaques produced by venular obstruction. Arch Neurol Neurosurg Psychiat. 1935, 33: 929-940.","journal-title":"Arch Neurol Neurosurg Psychiat"},{"key":"144_CR2","doi-asserted-by":"publisher","first-page":"1109","DOI":"10.1016\/S0140-6736(65)90069-3","volume":"2","author":"HP Wright","year":"1965","unstructured":"Wright HP, Thompson RHS, Zilkha KJ: Platelet adhesiveness in multiple sclerosis. Lancet. 1965, 2: 1109-1110.","journal-title":"Lancet"},{"issue":"7","key":"144_CR3","first-page":"462","volume":"28","author":"M Nathanson","year":"1952","unstructured":"Nathanson M, Savistsky JP: Platelet adhesive index studies in multiple sclerosis and other neurologic disorders. Bull N Y Acad Med. 1952, 28 (7): 462-468.","journal-title":"Bull N Y Acad Med"},{"key":"144_CR4","first-page":"66","volume-title":"The role of human platelet membrane receptors in inflammation [Ch 4]. In: Joseph M, ed. Immunopharmacology of Platelets","author":"JL McGregor","year":"1995","unstructured":"McGregor JL: The role of human platelet membrane receptors in inflammation [Ch 4]. In: Joseph M, ed. Immunopharmacology of Platelets. 1995, London\/New York: Academic Press, 66-82."},{"key":"144_CR5","doi-asserted-by":"publisher","first-page":"1897","DOI":"10.1046\/j.1538-7836.2003.00304.x","volume":"1","author":"AS Weyrich","year":"2003","unstructured":"Weyrich AS, Lindemann S, Zimmerman CA: The evolving role of platelets in inflammation. J Thromb Haemost. 2003, 1: 1897-1905.","journal-title":"J Thromb Haemost"},{"key":"144_CR6","first-page":"293","volume":"3","author":"WA Sheremata","year":"1993","unstructured":"Sheremata WA, Fineberg M, Ahn YS: Association of immune thrombocytopenia and abnormal platelet functions with multiple sclerosis (Abstract). Brain Pathol. 1993, 3: 293.","journal-title":"Brain Pathol"},{"key":"144_CR7","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1016\/S0190-9622(97)70170-1","volume":"37","author":"GW Elgart","year":"1997","unstructured":"Elgart GW, Sheremata W, Ahn YS: Cutaneous reactions to recombinant human interferon beta-1b: the clinical and histologic spectrum. J Am Acad Dermatol. 1997, 37: 553-558.","journal-title":"J Am Acad Dermatol"},{"key":"144_CR8","first-page":"334","volume":"119","author":"W Jy","year":"1992","unstructured":"Jy W, Horstman LL, Arce M, Ahn YS: Clinical significance of platelet microparticles in autoimmune thrombocytopenias. J Lab Clin Med. 1992, 119: 334-345.","journal-title":"J Lab Clin Med"},{"key":"144_CR9","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1016\/0049-3848(93)90138-E","volume":"72","author":"YJ Lee","year":"1993","unstructured":"Lee YJ, Horstman LL, Janania J, Reyes Y, Kelley RE, Ahn YS: Elevated platelet microparticles in transient ischemic attacks, lacunar infarcts, and multiinfarct dementias. Thromb Res. 1993, 72: 295-304.","journal-title":"Thromb Res"},{"key":"144_CR10","first-page":"515","volume":"123","author":"LL Horstman","year":"1994","unstructured":"Horstman LL, Jy W, Schultz DR, Mao WW, Ahn YS: Complement mediated fragmentation and lysis of opsonized platelets: Gender differences in sensitivity. J Lab Clin Med. 1994, 123: 515-525.","journal-title":"J Lab Clin Med"},{"key":"144_CR11","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1016\/0049-3848(95)00102-W","volume":"79","author":"LL Horstman","year":"1995","unstructured":"Horstman LL, Valle-Riestra BJ, Jy W, Wang F, Mao W, Ahn YS: Desmopressin [DDAVP] acts on platelets to generate platelet microparticles and enhanced procoagulant activity. Thromb Res. 1995, 79: 163-174.","journal-title":"Thromb Res"},{"key":"144_CR12","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1046\/j.1365-2141.2001.02516.x","volume":"112","author":"J Jimenez","year":"2001","unstructured":"Jimenez J, Jy W, Mauro L, Horstman L, Ahn Y: Elevated endothelial microparticles in thrombotic thrombocytopenic purpura (TTP): Findings from brain and renal microvascular cell culture and patients with active disease. Br J Haematol. 2001, 112: 81-90.","journal-title":"Br J Haematol"},{"key":"144_CR13","doi-asserted-by":"publisher","first-page":"408","DOI":"10.1046\/j.1365-2141.1996.d01-1902.x","volume":"95","author":"YS Ahn","year":"1996","unstructured":"Ahn YS, Jy W, Kolodny L, Horstman LL, Mao WW, Valant PA, Duncan RC: Activated platelet aggregates in thrombotic thrombocytopenic purpura: decrease with plasma infusions and normalization in remission. Br J Haematol. 1996, 95: 408-415.","journal-title":"Br J Haematol"},{"key":"144_CR14","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1002\/(SICI)1096-8652(199801)57:1<33::AID-AJH6>3.0.CO;2-2","volume":"57","author":"W Jy","year":"1998","unstructured":"Jy W, Horstman LL, Park H, Mao W, Valant P, Ahn YS: Platelet aggregates as markers of platelet activation: Characterization of flow cytometric method suitable for clinical applications. Am J Hematol. 1998, 57: 33-42.","journal-title":"Am J Hematol"},{"key":"144_CR15","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.1055\/s-0037-1614371","volume":"82","author":"W Jy","year":"1999","unstructured":"Jy W, Mao WW, Horstman LL, Valant PA, Ahn YS: A flow cytometric assay of platelet activation marker P-selectin (CD62p) distinguishes heparin-induced thrombocytopenia (HIT) from HIT-with-thrombosis (HITT). Thromb Haemost. 1999, 82: 1255-1259.","journal-title":"Thromb Haemost"},{"key":"144_CR16","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1177\/107602969700300107","volume":"3","author":"MD Ozner","year":"1997","unstructured":"Ozner MD, Ahn YS, Horstman LL, Wenche Jy, Kolodny L, Myerberg RJ: Chronic platelet activation and acute coronary syndromes in 13 middle-aged patients. Clin Appl Thromb Hemost. 1997, 3: 46-53.","journal-title":"Clin Appl Thromb Hemost"},{"key":"144_CR17","doi-asserted-by":"publisher","first-page":"723","DOI":"10.7326\/0003-4819-111-9-723","volume":"111","author":"YS Ahn","year":"1989","unstructured":"Ahn YS, Rocha R, Mylvaganam R, Duncan RC, Harrington WJ: Long-term danazol therapy in ITP: unmaintained remissions and age dependent response in women. Ann Int Med. 1989, 111: 723-729.","journal-title":"Ann Int Med"},{"key":"144_CR18","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1016\/0049-3848(95)00202-2","volume":"80","author":"W Jy","year":"1995","unstructured":"Jy W, Horstman LL, Wang F, Duncan R, Ahn YS: Platelet factor 3 in plasma fractions: Its relation to microparticle size and thromboses. Thromb Res. 1995, 80: 471-482.","journal-title":"Thromb Res"},{"key":"144_CR19","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1080\/09537100220146398","volume":"13","author":"FA Siddiqui","year":"2002","unstructured":"Siddiqui FA, Desai H, Amirkhosravi A, Amaya M, Francis JL: The presence and release of tissue factor from human platelets. Platelets. 2002, 13: 247-253.","journal-title":"Platelets"},{"key":"144_CR20","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1055\/s-0037-1613351","volume":"88","author":"T Scholz","year":"2002","unstructured":"Scholz T, Temmler U, Krause S, Heptinstall S, Losche W: Transfer of tissue factor from platelets to monocytes: role of platelet-derived microvesicles and CD62P. Thromb Haemost. 2002, 88: 1033-1038.","journal-title":"Thromb Haemost"},{"key":"144_CR21","doi-asserted-by":"crossref","first-page":"940","DOI":"10.1160\/TH03-02-0097","volume":"90","author":"CE Ahnadi","year":"2003","unstructured":"Ahnadi CE, Sabrinah Chapman E, Lepine M, Okrongly D, Pujol-Moix N, Hemandez A, Boughrassa F, Grant AM: Assessment of platelet activation in several different anticoagulants by the Advia 120 Hematology System, fluorescence flow cytometry, and electron microscopy. Thromb Haemost. 2003, 90: 940-948.","journal-title":"Thromb Haemost"},{"key":"144_CR22","doi-asserted-by":"publisher","first-page":"1319","DOI":"10.1212\/WNL.56.10.1319","volume":"56","author":"A Minagar","year":"2001","unstructured":"Minagar A, Jy W, Jimenez JJ, Sheremata WA, Mauro LM, Mao WW, Horstman LL, Ahn YS: Elevated plasma endothelial microparticles in multiple sclerosis. Neurology. 2001, 56: 1319-1324.","journal-title":"Neurology"},{"key":"144_CR23","doi-asserted-by":"publisher","first-page":"1020","DOI":"10.1056\/NEJM200010053431407","volume":"343","author":"UH von Andrian","year":"2000","unstructured":"von Andrian UH, MacKay CR: T-cell function and migration: Two sides of the same coin. N Engl J Med. 2000, 343: 1020-1034.","journal-title":"N Engl J Med"},{"key":"144_CR24","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1016\/S0074-7742(07)79010-4","volume":"79","author":"LL Horstman","year":"2007","unstructured":"Horstman LL, Minagar A, Jy W, Bidot CJ, Jimenez JJ, Alexander JS, Ahn YS: Cell-derived microparticles and exosomes in neuroinflammatory conditions [Review]. Int Rev Neurobiol. 2007, 79: 227-268.","journal-title":"Int Rev Neurobiol"},{"key":"144_CR25","doi-asserted-by":"publisher","first-page":"1487","DOI":"10.1038\/sj.leu.2404296","volume":"20","author":"J Ratajczak","year":"2006","unstructured":"Ratajczak J, Wysoczynski M, Hayek F, Janowska-Wieczorek A, Ratajczak MZ: Membrane-derived microvesicles: Important and under-appreciated mediators of cel-to-cell communication. Leukemia. 2006, 20: 1487-1495.","journal-title":"Leukemia"},{"key":"144_CR26","doi-asserted-by":"publisher","first-page":"376","DOI":"10.1046\/j.1365-2141.2003.04773.x","volume":"124","author":"HK Kim","year":"2004","unstructured":"Kim HK, Song KS, Chung JH, Lee KR, Lee SN: Platelet microparticles induce angiogenesis in vitro. Br J Haematol. 2004, 124: 376-384.","journal-title":"Br J Haematol"},{"key":"144_CR27","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1016\/j.cardiores.2005.04.007","volume":"67","author":"A Brill","year":"2005","unstructured":"Brill A, Dashevsky O, Rivo J, Gozal Y, Varon D: Platelet-derived microparticles induce angiogenesis and stimulate post-ischemic revascularization. Cardiovasc Res. 2005, 67: 30-38.","journal-title":"Cardiovasc Res"},{"key":"144_CR28","doi-asserted-by":"crossref","first-page":"709a","DOI":"10.1182\/blood.V104.11.2589.2589","volume":"104","author":"A Welterman","year":"2004","unstructured":"Welterman A, Hron G, Kollars M: The association between tissue factor-exposing microparticles and the activation of the coagulation system in cancer patients. Blood. 2004, 104: 709a-(Abstract 2589)","journal-title":"Blood"},{"key":"144_CR29","doi-asserted-by":"publisher","first-page":"752","DOI":"10.1002\/ijc.20657","volume":"113","author":"A Janowska-Wieczorek","year":"2005","unstructured":"Janowska-Wieczorek A, Wysoczynski M, Kijowski J, Marquez-Curtis L, Machalinski B, Ratajczak J, Ratajczak MZ: Microvesicles derived from activated platelets induce metastasis and angiogenesis in lung cancer. Int J Cancer. 2005, 113: 752-760.","journal-title":"Int J Cancer"},{"key":"144_CR30","doi-asserted-by":"crossref","first-page":"4046","DOI":"10.1182\/blood.V96.13.4046","volume":"96","author":"KJ Clemetson","year":"2000","unstructured":"Clemetson KJ, Clemetson JM, Proudfoot AE, Power CA, Baggiolini M, Wells TN: Functional expression of CCR1, CCR3, CCR4, and CXCR4 chemokine receptors on human platelets. Blood. 2000, 96: 4046-4054.","journal-title":"Blood"},{"key":"144_CR31","doi-asserted-by":"publisher","first-page":"1512","DOI":"10.1161\/01.ATV.0000170133.43608.37","volume":"25","author":"SF Mause","year":"2005","unstructured":"Mause SF, von Hundelshausen P, Zernecke A, Koenen RR, Weber C: Platelet microparticles, a transcellular delivery system for RANTES promoting monocyte recruitment on endothelium. Arterioscl Thromb Vasc Biol. 2005, 25: 1512-1518.","journal-title":"Arterioscl Thromb Vasc Biol"},{"key":"144_CR32","doi-asserted-by":"publisher","first-page":"825","DOI":"10.1016\/S1074-7613(01)00229-1","volume":"8","author":"A MacKenzie","year":"2001","unstructured":"MacKenzie A, Wilson HL, Kiss-Toth E, Dower SK, North RA, Surprenant A: Rapid secretion of interleukin-1\u03b2 by microvesicle shedding. Immunity. 2001, 8: 825-835.","journal-title":"Immunity"},{"key":"144_CR33","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1097\/00002030-200301030-00006","volume":"17","author":"T Rozmyslowicz","year":"2003","unstructured":"Rozmyslowicz T, Majka M, Kijowski J, Murphy SL, Conover DO, Poncz M, Ratajczak J, Gaulton GN, Ratajczak MZ: Platelet- and megakaryocyte-derived microparticles transfer CXCR4 receptor to CXCR4-null cells and make them susceptible to infection by X4-HIV. AIDS. 2003, 17: 33-42.","journal-title":"AIDS"},{"issue":"3","key":"144_CR34","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1006\/bcmd.1995.0025","volume":"21","author":"W Jy","year":"1995","unstructured":"Jy W, Mao WW, Horstman LL, Tao J, Ahn YS: Platelet microparticles bind, activate and aggregate neutrophils in vitro. Blood Cells Mol Dis. 1995, 21 (3): 217-231.","journal-title":"Blood Cells Mol Dis"},{"key":"144_CR35","doi-asserted-by":"publisher","first-page":"1076","DOI":"10.1038\/nature06559","volume":"451","author":"MH Han","year":"2008","unstructured":"Han MH, Hwang SU, Roy DB, Lundgren DH, Price JV, Ousman SS, Fernald GH, Gerlitz B, Robinson WH, Baranzini SE, Grinnell BW, Raine CS, Sobel RA, Han DK, Steinman L: Proteomic analysis of active multiple sclerosis lesions reveals therapeutic targets. Nature. 2008, 451: 1076-1081.","journal-title":"Nature"},{"key":"144_CR36","doi-asserted-by":"publisher","first-page":"1271","DOI":"10.1016\/S0248-8663(01)00502-1","volume":"22","author":"H Granier","year":"2001","unstructured":"Granier H, Bellard S, Nicholas X, Laborde JP, Thlarmin F: Association sclerose en plaques et thrombopenie auto-immune. Rev Med Interne. 2001, 22: 1271-7.","journal-title":"Rev Med Interne"},{"key":"144_CR37","doi-asserted-by":"publisher","first-page":"S210","DOI":"10.1191\/135248506ms1254oa","volume":"12","author":"E Munteis","year":"2006","unstructured":"Munteis E, Segura N, Martinez JE, Cuadrado E, Galvez A, Roquer J: Idiopathic thrombocytopenic purpura in patients with multiple sclerosis. (Abstract). Multiple Sclerosis. 2006, 12: S210.","journal-title":"Multiple Sclerosis"},{"key":"144_CR38","first-page":"96","volume":"12","author":"A Madrid","year":"1997","unstructured":"Madrid A, Ucles A, Gonzalez-Marcos JR, Gil-Peralta A: Relacion entree sclerosis multiple, enfermedad de Hodgkin y purpura trombocitopenica idiopatica. Relations among multiple sclerosis, Hodgkin's disease and idiopathic thrombocytopenic purpura. Neurologia. 1997, 12: 96-97.","journal-title":"Neurologia"},{"issue":"11","key":"144_CR39","doi-asserted-by":"publisher","first-page":"2377","DOI":"10.1111\/j.1538-7836.2006.02147.x","volume":"4","author":"JB Segal","year":"2006","unstructured":"Segal JB, Powe NR: Prevalence of immune thrombocytopenia: analyses of administrative data. J Thromb Haemost. 2006, 4 (11): 2377-2883.","journal-title":"J Thromb Haemost"},{"issue":"Suppl 1","key":"144_CR40","first-page":"S29","volume":"11","author":"S Kirby","year":"2005","unstructured":"Kirby S, Brown MG, Murray TJ, Fisk JD, Stadnyk K, MacKinnon-Cameron D, Bhan V: Prevalence of other autoimmune diseases in patients with multiple sclerosis. Multiple Sclerosis. 2005, 11 (Suppl 1): S29.","journal-title":"Multiple Sclerosis"},{"key":"144_CR41","doi-asserted-by":"crossref","first-page":"2641","DOI":"10.1182\/blood.V77.12.2641.2641","volume":"77","author":"G Tans","year":"1991","unstructured":"Tans G, Rosing J, Thomassen MC, Heeb MJ, Zwaal RF, Griffin JH: Comparison of anticoagulant and procoagulant activities of stimulated platelets and platelet-derived microparticles. Blood. 1991, 77: 2641-2648.","journal-title":"Blood"},{"issue":"3","key":"144_CR42","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1620\/tjem.178.203","volume":"178","author":"Y Sugiyama","year":"1996","unstructured":"Sugiyama Y, Yamamoto Y: Characterization of serum anti-phospholipid antibodies in patients with multiple sclerosis. Tohoku J Exp Med. 1996, 178 (3): 203-215.","journal-title":"Tohoku J Exp Med"},{"key":"144_CR43","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1186\/1471-2377-7-36","volume":"7","author":"CJ Bidot","year":"2007","unstructured":"Bidot CJ, Horstman LL, Jy W, Jimenez JJ, Bidot C, Ahn YS, Alexander JS, Minagar A: Clinical and neuroimaging correlates of antiphospholipid antibodies in multiple sclerosis: a preliminary study. BMC Neurol. 2007, 7: 36.","journal-title":"BMC Neurol"},{"key":"144_CR44","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1097\/00005792-200001000-00006","volume":"79","author":"MJ Cuadrado","year":"2000","unstructured":"Cuadrado MJ, Khamashta MA, Ballesteros A, Godfrey T, Simon MJ, Hughes GR: Can neurological manifestations of Hughes (antiphospholipid) syndrome be distinguished from multiple sclerosis? Analysis of 27 patients and review of the literature. Medicine (Baltimore). 2000, 79: 57-68.","journal-title":"Medicine (Baltimore)"},{"key":"144_CR45","doi-asserted-by":"publisher","first-page":"909","DOI":"10.2165\/00023210-200519110-00002","volume":"19","author":"W Sheremata","year":"2005","unstructured":"Sheremata W, Minagar A, Alexander J, Vollmer T: The role of alpha-4 Integrin in the aetiology of multiple sclerosis: current knowledge and therapeutic implications. CNS Drugs. 2005, 19: 909-922.","journal-title":"CNS Drugs"}],"container-title":["Journal of Neuroinflammation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/1742-2094-5-27.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,8,31]],"date-time":"2021-08-31T23:03:17Z","timestamp":1630450997000},"score":1,"resource":{"primary":{"URL":"https:\/\/jneuroinflammation.biomedcentral.com\/articles\/10.1186\/1742-2094-5-27"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,6,27]]},"references-count":45,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2008,12]]}},"alternative-id":["144"],"URL":"https:\/\/doi.org\/10.1186\/1742-2094-5-27","relation":{},"ISSN":["1742-2094"],"issn-type":[{"value":"1742-2094","type":"electronic"}],"subject":[],"published":{"date-parts":[[2008,6,27]]},"assertion":[{"value":"3 March 2008","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 June 2008","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 June 2008","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"27"}}